These genes, EGFR, COL4A1, and CDK4 all shared the ‘pathways to cancer’ annotation; and EGFR and COL4A1 were shown to be involved specific cancers such as glioma, melanoma, lung cancer, bladder cancer, and pancreatic cancer. This evidence concerns the gene EGFR and glioma.